# Collegium Pharmaceutical, Inc: Form 8-K, filed Dec 4, 2017

- Company: [Collegium Pharmaceutical, Inc](/companies/coll.md) (CIK 1267565)
- Form: 8-K
- Filed: 2017-12-04
- Accepted by EDGAR: Dec 4, 2017, 16:36 ET
- Period: 2017-12-04
- Accession: 0001104659-17-071702
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1267565/000110465917071702/a17-27912_18k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1267565/000110465917071702/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 7.01: Regulation FD disclosure
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1267565/000110465917071702/a17-27912_18k.htm

Filed Dec 4, 2017.
Source: SEC EDGAR, the filing index for accession 0001104659-17-071702. Last ingested by Listed: Nov 10, 2026, 23:07 ET. No prices; not investment advice.
